HiBob Named Best HR Management Software in the UK for 2026 
Ionik Announces 30-Day Extension of Senior Debt Facility 
NTG Clarity to Announce First Quarter Financial Results on May 27, 2026 with Earnings Call to Follow 
Voghion Expands Beyond Fashion to Build a One-Stop Lifestyle Platform Across Europe Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin
REDWOOD CITY, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading…
Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022
OAKS met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a…
Gritstone to Host Data Update on Neoantigen Oncology Programs for the Treatment of Solid Tumors During ESMO 2021
EMERYVILLE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
Rezolute Announces Initiation of Dosing in the Second Cohort of its Phase 2b Trial of RZ358 for Congenital Hyperinsulinism
Tracking to Announce Top line data in Q1 2022 REDWOOD CITY, Calif., Sept. 09, 2021…
AnaptysBio to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
TScan Therapeutics Appoints Zoran Zdraveski, J.D., Ph.D. as Chief Legal Officer
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a biopharmaceutical…
Oncternal Therapeutics to Participate in September Investor Conferences
SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Tempest to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
Mountain Valley MD Holdings Announces Annual Shareholder Meeting
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Oxurion NV Business & Financial Update – H1 2021
Developing Next generation Standard of Care Ophthalmic Therapies Addressing Unmet Medical Needs in Retinal Vascular…
Rakovina Therapeutics to Present at the JCA-AACR Precision Medicine International Conference
VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (“the…
Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies
Business combination with Blue Water Acquisition Corp., a special purpose acquisition company, completed on September 9, 2021 Combined company to be…
Notification on convocation of the Joint Stock Company “Olainfarm” Extraordinary General Meeting of Shareholders
The Management Board of joint stock company “Olainfarm”, registration number: 40003007246, legal address: Rūpnīcu iela…
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
IRVINE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
— Investigational EIF2B activator approach has potential to be a first-in-class treatment for ALS — SOUTH…
Syneos Health and Ride Health Partner to Improve Clinical Trial Recruitment and Retention
Partnership Creates a More Patient-centric Travel Experience, Drives Adherence and Advances Diversity and Inclusion in…
TG Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
Fireside chat available for on demand download at 7:00 AM ET on Monday, September 13,…
Medicenna Therapeutics to Present at Upcoming September Investor Conferences
TORONTO and HOUSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
PharmaTher to Present at H.C. Wainwright 23rd Annual Global Investment Conference
To provide an update on PharmaTher’s product pipeline and upcoming milestones on its FDA Phase…
Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its Novel Psilocybin-Inspired Clinical Candidate
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…